GR3027697T3 - Novel anticoagulant cofactor activity - Google Patents
Novel anticoagulant cofactor activityInfo
- Publication number
- GR3027697T3 GR3027697T3 GR980401874T GR980401874T GR3027697T3 GR 3027697 T3 GR3027697 T3 GR 3027697T3 GR 980401874 T GR980401874 T GR 980401874T GR 980401874 T GR980401874 T GR 980401874T GR 3027697 T3 GR3027697 T3 GR 3027697T3
- Authority
- GR
- Greece
- Prior art keywords
- activity
- apc
- protein
- component
- human
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 3
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229940127219 anticoagulant drug Drugs 0.000 title 1
- 108010014172 Factor V Proteins 0.000 abstract 3
- 229940096437 Protein S Drugs 0.000 abstract 3
- 102000029301 Protein S Human genes 0.000 abstract 3
- 108010066124 Protein S Proteins 0.000 abstract 3
- 239000003130 blood coagulation factor inhibitor Substances 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 239000000758 substrate Substances 0.000 abstract 3
- 101800004937 Protein C Proteins 0.000 abstract 2
- 102000017975 Protein C Human genes 0.000 abstract 2
- 101800001700 Saposin-D Proteins 0.000 abstract 2
- 239000012911 assay medium Substances 0.000 abstract 2
- 230000023555 blood coagulation Effects 0.000 abstract 2
- 230000005714 functional activity Effects 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229960000856 protein c Drugs 0.000 abstract 2
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 abstract 1
- 101710112282 Adenomatous polyposis coli protein Proteins 0.000 abstract 1
- 230000010100 anticoagulation Effects 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 108010074361 factor V clotting antigen Proteins 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96461—Protein C (3.4.21.69)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96463—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9300300A SE9300300D0 (sv) | 1993-01-29 | 1993-01-29 | A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity |
SE9302457A SE9302457D0 (sv) | 1993-07-20 | 1993-07-20 | A novel anticoagulant entity, antibodies reacting specifically with the enety, and diagnostic and therapeutic uses of the entity |
PCT/SE1994/000070 WO1994017415A1 (en) | 1993-01-29 | 1994-01-28 | Novel anticoagulant cofactor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3027697T3 true GR3027697T3 (en) | 1998-11-30 |
Family
ID=26661641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR980401874T GR3027697T3 (en) | 1993-01-29 | 1998-08-20 | Novel anticoagulant cofactor activity |
Country Status (17)
Country | Link |
---|---|
US (2) | US7169572B1 (el) |
EP (1) | EP0690991B2 (el) |
JP (1) | JPH08506181A (el) |
AT (1) | ATE168781T1 (el) |
AU (1) | AU690535B2 (el) |
BR (1) | BR9406223A (el) |
CA (1) | CA2154080C (el) |
CZ (1) | CZ184995A3 (el) |
DE (1) | DE69411898T3 (el) |
DK (1) | DK0690991T4 (el) |
ES (1) | ES2119165T5 (el) |
FI (1) | FI953565A0 (el) |
GR (1) | GR3027697T3 (el) |
HU (1) | HUT72191A (el) |
NZ (1) | NZ261190A (el) |
PL (1) | PL181102B1 (el) |
WO (1) | WO1994017415A1 (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ261190A (en) * | 1993-01-29 | 1997-12-19 | Bjorn Dahlback | Assaying for functional activity of a blood coagulation component involved in the protein c anticoagulant system (protein c, activated protein c, protein s or anticoagulant factor v) |
JP3163105B2 (ja) * | 1994-02-14 | 2001-05-08 | リヤクス・ユニフアーシテイト・レイデン | 血栓症及び/又は活性化プロテインcに対する弱い抗凝血応答に関連した遺伝性欠陥の存在をスクリーニングする方法 |
DE4418635C2 (de) * | 1994-05-27 | 1997-07-24 | Immuno Ag | Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen |
DE4439756C2 (de) * | 1994-11-09 | 2002-07-18 | Dade Behring Marburg Gmbh | Kalibrator zur Verwendung in Testverfahren zum Nachweis eines defekten Gerinnungsfaktors V |
ATE198772T1 (de) * | 1994-11-10 | 2001-02-15 | Dade Behring Marburg Gmbh | Verfahren zum spezifischen nachweis eines aktivierten gerinnungsfaktors v mit einer erhöhten stabilität gegenüber aktiviertem protein c |
US6867045B1 (en) * | 1994-11-14 | 2005-03-15 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
EP0718628B2 (en) * | 1994-12-23 | 2005-02-23 | Diagnostic Reagents Limited | Method for diagnosis of blood coagulation disorders |
US5874256A (en) * | 1995-06-06 | 1999-02-23 | Rijks Universiteit Leiden | Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same |
US5863896A (en) * | 1995-11-09 | 1999-01-26 | Immuno Ag | Evaluation of substances for altering and for increasing APC response |
US5766869A (en) * | 1995-11-30 | 1998-06-16 | Ahs Hospital Corp. | Factor V ratio blood test for susceptibility to thromboembolism |
DE19634312A1 (de) * | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma |
JP2002514433A (ja) * | 1998-05-14 | 2002-05-21 | バッテル メモリアル インスティテュート | トランスジェニック植物由来ヒト凝血因子 |
FR2778923B1 (fr) * | 1998-05-22 | 2000-08-18 | Stago Diagnostica | Compositions utiles comme controle pathologique dans une methode de detection d'une resistance a la proteine c activee, procede de preparation de ces compositions et utilisation dans ladite methode de detection |
JP4377207B2 (ja) | 2003-11-28 | 2009-12-02 | シスメックス株式会社 | 血液凝固時間測定方法および血液凝固時間測定用試薬 |
CA2666905A1 (en) * | 2006-10-16 | 2008-06-05 | Novelmed Therapeutics, Inc. | Method of inhibiting coagulation with human anti-factor va antibodies and use thereof |
JP6962338B2 (ja) * | 2017-01-06 | 2021-11-05 | ソニーグループ株式会社 | 血液凝固系解析装置、血液凝固系解析システム、血液凝固系解析方法、及び血液凝固系解析用プログラム、並びに、出血量予測装置、出血量予測システム、出血量予測方法、及び出血量予測用プログラム |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3330699A1 (de) | 1983-08-25 | 1985-03-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur gleichzeitigen bestimmung von fibrinogen und fibrinogen-spaltprodukten im plasma |
JPS60241900A (ja) | 1984-05-16 | 1985-11-30 | Nitto Boseki Co Ltd | 新規な第Xa因子活性測定用基質 |
DE3516579A1 (de) | 1984-11-19 | 1986-05-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Gerinnungstest auf teststreifen |
US4849403A (en) | 1985-05-29 | 1989-07-18 | Pentapharm Ag | Protein C activator, methods of preparation and use thereof |
DE3536903A1 (de) | 1985-10-16 | 1987-04-16 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung von protein c |
DE3607559A1 (de) | 1986-03-07 | 1987-09-10 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet |
US5200322A (en) * | 1986-09-19 | 1993-04-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for assaying protein C and measuring kit for the same |
CA1339946C (en) | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Ultrapurification process for polypeptides |
US5472850A (en) | 1991-04-10 | 1995-12-05 | Oklahoma Medical Research Foundation | Quantitative clotting assay for activated factor VII |
US5055412A (en) | 1989-03-21 | 1991-10-08 | Proksch Gary J | Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same |
IT1230744B (it) * | 1989-07-07 | 1991-10-29 | Instrumentation Lab Spa | Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano. |
US5051357A (en) | 1989-07-14 | 1991-09-24 | Board Of Trustees Operating Michigan State University | Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor |
SE464135B (sv) | 1989-07-14 | 1991-03-11 | Kabivitrum Ab | Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov |
WO1991001383A1 (en) | 1989-07-14 | 1991-02-07 | Michigan State University | Method for diagnosing blood clotting disorders |
US5169786A (en) | 1989-12-19 | 1992-12-08 | Ortho Diagnostic Systems, Inc. | Method of determining levels of extrinsic and intrinsic clotting factors and protein c |
US5314695A (en) | 1990-11-13 | 1994-05-24 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
AT395597B (de) | 1991-01-25 | 1993-01-25 | Immuno Ag | Reagens zur bestimmung von faktor viii-aktivitaet |
US5716795A (en) * | 1991-10-04 | 1998-02-10 | Matschiner; John T. | Thrombomodulin-based coagulometric assay of the protein C system |
WO1993007491A1 (en) * | 1991-10-04 | 1993-04-15 | Board Of Regents Of The University Of Nebraska | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
SE470274B (sv) | 1991-11-13 | 1993-12-20 | Bjoern Dahlbaeck | Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar |
ES2081618T5 (es) * | 1991-11-13 | 2005-09-01 | T.A.C. Thrombosis And Coagulation Aktiebolag | Metodo para diagnosticar anomalias de la coagulacion de la sangre. |
US5308756A (en) * | 1991-11-20 | 1994-05-03 | Baxter Diagnostics Inc. | Protein S chromogenic assay |
NZ261190A (en) * | 1993-01-29 | 1997-12-19 | Bjorn Dahlback | Assaying for functional activity of a blood coagulation component involved in the protein c anticoagulant system (protein c, activated protein c, protein s or anticoagulant factor v) |
DE59410041D1 (de) * | 1993-12-03 | 2002-03-21 | Baxter Ag | Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C |
DE4427785A1 (de) * | 1994-08-08 | 1996-02-15 | Behringwerke Ag | Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems |
DE4439756C2 (de) * | 1994-11-09 | 2002-07-18 | Dade Behring Marburg Gmbh | Kalibrator zur Verwendung in Testverfahren zum Nachweis eines defekten Gerinnungsfaktors V |
US5705395A (en) * | 1994-11-14 | 1998-01-06 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
US5780255A (en) * | 1995-06-09 | 1998-07-14 | Instrumentation Laboratory, S.P.A. | Protein C pathway screening test |
US20030143759A1 (en) | 1995-10-20 | 2003-07-31 | Bjorn Dahlback | Assays for determining anticoagulant cofactor activity |
US5766869A (en) * | 1995-11-30 | 1998-06-16 | Ahs Hospital Corp. | Factor V ratio blood test for susceptibility to thromboembolism |
-
1994
- 1994-01-28 NZ NZ261190A patent/NZ261190A/en not_active IP Right Cessation
- 1994-01-28 CA CA002154080A patent/CA2154080C/en not_active Expired - Lifetime
- 1994-01-28 DE DE69411898T patent/DE69411898T3/de not_active Expired - Lifetime
- 1994-01-28 EP EP94905908A patent/EP0690991B2/en not_active Expired - Lifetime
- 1994-01-28 AU AU59827/94A patent/AU690535B2/en not_active Expired
- 1994-01-28 DK DK94905908T patent/DK0690991T4/da active
- 1994-01-28 AT AT94905908T patent/ATE168781T1/de active
- 1994-01-28 JP JP6516938A patent/JPH08506181A/ja not_active Ceased
- 1994-01-28 PL PL94310050A patent/PL181102B1/pl not_active IP Right Cessation
- 1994-01-28 BR BR9406223A patent/BR9406223A/pt not_active Application Discontinuation
- 1994-01-28 WO PCT/SE1994/000070 patent/WO1994017415A1/en not_active Application Discontinuation
- 1994-01-28 HU HU9502190A patent/HUT72191A/hu unknown
- 1994-01-28 US US08/500,917 patent/US7169572B1/en active Active
- 1994-01-28 ES ES94905908T patent/ES2119165T5/es not_active Expired - Lifetime
- 1994-01-28 CZ CZ951849A patent/CZ184995A3/cs unknown
-
1995
- 1995-07-26 FI FI953565A patent/FI953565A0/fi not_active Application Discontinuation
-
1998
- 1998-08-20 GR GR980401874T patent/GR3027697T3/el unknown
-
2006
- 2006-11-16 US US11/560,502 patent/US20070212743A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU690535B2 (en) | 1998-04-30 |
EP0690991A1 (en) | 1996-01-10 |
ES2119165T5 (es) | 2004-07-01 |
ATE168781T1 (de) | 1998-08-15 |
EP0690991B1 (en) | 1998-07-22 |
ES2119165T3 (es) | 1998-10-01 |
CA2154080C (en) | 2006-03-21 |
CZ184995A3 (en) | 1996-03-13 |
FI953565A (fi) | 1995-07-26 |
HU9502190D0 (en) | 1995-09-28 |
PL310050A1 (en) | 1995-11-13 |
DE69411898T2 (de) | 1998-12-17 |
FI953565A0 (fi) | 1995-07-26 |
AU5982794A (en) | 1994-08-15 |
DK0690991T3 (da) | 1999-02-01 |
DK0690991T4 (da) | 2004-02-16 |
DE69411898D1 (de) | 1998-08-27 |
CA2154080A1 (en) | 1994-08-04 |
US20070212743A1 (en) | 2007-09-13 |
JPH08506181A (ja) | 1996-07-02 |
PL181102B1 (pl) | 2001-05-31 |
US7169572B1 (en) | 2007-01-30 |
DE69411898T3 (de) | 2004-07-08 |
NZ261190A (en) | 1997-12-19 |
WO1994017415A1 (en) | 1994-08-04 |
BR9406223A (pt) | 1996-01-09 |
HUT72191A (en) | 1996-03-28 |
EP0690991B2 (en) | 2004-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3027697T3 (en) | Novel anticoagulant cofactor activity | |
TWI256975B (en) | Compositions containing a urea derivative dye for detecting an analyte and methods for using the same | |
CA2334935A1 (en) | Screening for blood coagulation defects using metal ions | |
DK0420332T3 (da) | Fremgangsmåde til bestemmelse af det endogene trombinpotentiale af plasma og blod, samt et kit til anvendelse ved fremgangsmåden | |
GB2321967A (en) | Opaque reaction matrix for the analysis of whole blood | |
ATE202705T1 (de) | Verwendung von aktivitätsmindernden effektoren der dipeptidyl peptidase iv zur senkung des blutglukosespiegels in säugern | |
IL158743A0 (en) | Polynucleotide sequencing method | |
AU3772495A (en) | Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state | |
JPS57178161A (en) | Reagent for optically measuring blood coagulation reaction | |
Sakai et al. | Determination of 5′-nucleotidase activity in human erythrocytes and plasma using high-performance liquid chromatography | |
AU6385498A (en) | Reagent for determining aptt | |
DE3850346D1 (de) | Verfahren zur Selbstdurchführung von Enzymkinetik. | |
FI901468A0 (fi) | Testipakkaus entsyymien määritykseen ja määritysmenetelmä | |
CA2213083A1 (en) | Detection of antibody production | |
NO920624L (no) | Reagens for paavisning av fibrinolytisk aktivitet | |
DE59309254D1 (de) | Verwendung von Prothrombinfragmenten | |
CA2105606A1 (en) | Method for the determination of lupus anticoagulant antibodies that cause thrombosis | |
EP0188008A3 (de) | Verfahren zur Bestimmung der Aktivität des Komplementsystems des Blutes | |
ATE200710T1 (de) | Verfahren zur diagnose von blutgerinnungsstörungen |